Pyruvate Kinase Deficiency Epidemiological Study (PIECE)

Completed

Conditions studied: Pyruvate Kinase Deficiency

In brief

Pyruvate kinase deficiency (PKD) is the most common red cell glycolytic enzyme defect causing hereditary non-spherocytic hemolytic anemia, caused by mutations in the PKLR gene. The main goal of this study is the diagnosis of pyruvate kinase deficiency in patients who exhibit chronic anaemia and/or splenomegaly and/or judiance and/or hyperbilirubinemia and/or history of prolonged neonatal jaundice and/ or cholelithiasis of undetermined aetiology.

Key facts

Study ID
NCT03866590
Run by
CENTOGENE GmbH Rostock
People needed
75
Starts
2020-01-13
Expected to finish
2021-05-31
Last updated by the study team
2023-02-09

Who can join

Age: 5 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.